GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Maximus Inc (NYSE:MMS) » Definitions » Sloan Ratio %

Maximus (Maximus) Sloan Ratio % : -4.95% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Maximus Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Maximus's Sloan Ratio for the quarter that ended in Dec. 2023 was -4.95%.

As of Dec. 2023, Maximus has a Sloan Ratio of -4.95%, indicating the company is in the safe zone and there is no funny business with accruals.


Maximus Sloan Ratio % Historical Data

The historical data trend for Maximus's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maximus Sloan Ratio % Chart

Maximus Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.08 0.69 39.07 -0.80 -1.80

Maximus Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.26 -3.21 -1.58 -1.80 -4.95

Competitive Comparison of Maximus's Sloan Ratio %

For the Specialty Business Services subindustry, Maximus's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maximus's Sloan Ratio % Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Maximus's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Maximus's Sloan Ratio % falls into.



Maximus Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Maximus's Sloan Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Sloan Ratio=(Net Income (A: Sep. 2023 )-Cash Flow from Operations (A: Sep. 2023 )
-Cash Flow from Investing (A: Sep. 2023 ))/Total Assets (A: Sep. 2023 )
=(161.792-314.34
--80.963)/3985.797
=-1.80%

Maximus's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(185.945-470.607
--85.698)/4016.861
=-4.95%

Maximus's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 31.788 (Mar. 2023 ) + 30.863 (Jun. 2023 ) + 59.146 (Sep. 2023 ) + 64.148 (Dec. 2023 ) = $186 Mil.
Maximus's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 309.696 (Mar. 2023 ) + -5.286 (Jun. 2023 ) + 144.589 (Sep. 2023 ) + 21.608 (Dec. 2023 ) = $471 Mil.
Maximus's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -8.93 (Mar. 2023 ) + -25.112 (Jun. 2023 ) + -31.224 (Sep. 2023 ) + -20.432 (Dec. 2023 ) = $-86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Maximus  (NYSE:MMS) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Maximus has a Sloan Ratio of -4.95%, indicating the company is in the safe zone and there is no funny business with accruals.


Maximus Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Maximus's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Maximus (Maximus) Business Description

Traded in Other Exchanges
Address
1600 Tysons Boulevard, McLean, VA, USA, 22102
Maximus Inc is an operator of government health and human services programs in the United States, United Kingdom, Canada, Australia, and Saudi Arabia. The company offers business solutions to improve the cost-effectiveness, efficiency, and quality of government-sponsored benefit programs, such as Medicaid, Medicare, Health Insurance BC, and child support programmes. Most of its revenue is derived from long-term contractual arrangements with governments around the world. The company generates maximum revenue from the U.S. Federal Services segment.
Executives
Teresa Weipert officer: General Mgr US Federal Segment 1891 METRO CENTER DRIVE, RESTON VA 20190
Ilene R. Baylinson officer: Group General Manager 1891 METRO CENTER DRIVE, RESTON VA 20190
Michelle F. Link officer: Chief Human Resources Officer 1891 METRO CENTER DRIVE, RESTON VA 20190
Gayathri Rajan director 1891 METRO CENTER DRIVE, RESTON X1 20190
David Mutryn officer: Chief Financial Officer 1891 METRO CENTER DRIVE, RESTON VA 20190
Theresa D Golinvaux officer: Principal Accounting Officer 9300 LEE HIGHWAY, FAIRFAX VA 20131
John Thomas Martinez officer: Secretary and General Counsel 1600 TYSONS BLVD, #1400, MCLEAN VA 22102
Michael J. Warren director C/O WALKER & DUNLOP, INC., 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Bruce Caswell other: Group President - Human Svcs 11419 SUNSET HILLS ROAD, RESTON VA 20190-5207
Raymond B Ruddy director C/O MAXIMUS INC, 11419 SUNSET HILLS ROAD, RESTON VA 20190
David Francis officer: General Counsel C/O MAXIMUS INC, 11419 SUNSET HILLS RD, RESTON VA 20190
John J Haley director 901 N GLEBE ROAD, ARLINGTON VA 22203
Richard A Montoni director, officer: CEO and Director C/O MAXIMUS INC, 11419 SUNSET HILLS RD, RESTON VA 20190
Richard John Nadeau officer: Chief Financial Officer 1300 WILSON BLVD., SUITE 400, ARLINGTON VA 22209
Peter Pond director